Kura Oncology Inc (KURA) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.55x

Kura Oncology Inc (KURA) has a Cash Flow Reinvestment Rate of 0.55x as of December 2025, reinvesting $64.60 Million (capex $2.32 Million plus investments $-62.27 Million) from operating cash flow of $117.27 Million. See Kura Oncology Inc (KURA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.55x
(Capex + Investments) / Operating CF

Total Reinvested

$64.60 Million
Capex + Investments

Operating Cash Flow

$117.27 Million
USD

Capital Expenditures

$2.32 Million
USD

Kura Oncology Inc Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Kura Oncology Inc across 1 annual periods. For the full cash flow conversion analysis, see KURA cash generation efficiency.

Annual Cash Flow Reinvestment Rate for Kura Oncology Inc (2024–2024)

Year-by-year capital reinvestment analysis for Kura Oncology Inc. See KURA financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.76x $102.06 Million $134.32 Million $472.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow